Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / S&P PHARMAC
-
Total 13F shares
-
5,294,999
-
Share change
-
-373,238
-
Total reported value
-
$270,865,296
-
Put/Call ratio
-
159%
-
Price per share
-
$51.20
-
Number of holders
-
74
-
Value change
-
-$17,301,064
-
Number of buys
-
25
-
Number of sells
-
46
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q4 2015
As of 31 Dec 2015 SPDR SERIES TRUST - S&P PHARMAC (XPH) had 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 5,294,999 shares of stock of the company.
Largest 10 holders included GOLDMAN SACHS GROUP INC, MORGAN STANLEY, UBS Group AG, BANK OF AMERICA CORP /DE/, Psagot Investment House Ltd., Wharton Business Group, LLC, LPL Financial LLC, WELLS FARGO & COMPANY/MN, Baird Financial Group, Inc., and Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD.
This table shows 74 institutional shareholders of the security as of 31 Dec 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.